Cross-reactivity and Tolerability of Ertapenem in Patients With IgE-mediated Allergy to Beta-lactams.

Trial Profile

Cross-reactivity and Tolerability of Ertapenem in Patients With IgE-mediated Allergy to Beta-lactams.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Ertapenem (Primary) ; Beta-lactams
  • Indications Bacterial infections
  • Focus Adverse reactions
  • Most Recent Events

    • 14 Nov 2015 Status changed from recruiting to completed as per European Clinical Trials Database record.
    • 17 Mar 2012 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database.
    • 17 Mar 2012 New source identified and integrated (European Clinical Trials Database: EudraCT2009-017828-54).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top